TipRanks
Eupraxia Pharmaceuticals (EPRX)
NASDAQ:EPRX
US Market
EPRX
Eupraxia Pharmaceuticals
RESEARCH TOOLSreports

Eupraxia Pharmaceuticals (EPRX) Cash flow

46 Followers

Eupraxia Pharmaceuticals Cash Flow

EPRX's free cash flow for Q2 2026 was C$-12.91M. For the 2026 fiscal year, EPRX's free cash flow was decreased by C$447.42K and operating cash flow was C$-12.74M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Mar 24Dec 22Dec 21
Operating Cash Flow
$ -29.05M$ -29.99M$ -21.02MC$ -18.78MC$ -14.64M
Investing Cash Flow
$ -599.26K$ -75.16K$ -73.20KC$ 8.70MC$ -14.45M
Financing Cash Flow
$ 77.39M$ 45.78M$ 21.35MC$ 13.52MC$ 49.92M
End Cash Position
$ 80.42M$ 33.10M$ 19.30MC$ 24.74MC$ 20.89M
Free Cash Flow
$ -29.65M$ -30.10M$ -21.09MC$ -19.08MC$ -15.07M

Eupraxia Pharmaceuticals Cash Flow